Way v. United States

495 F. Supp. 1185
CourtDistrict Court, W.D. Oklahoma
DecidedJuly 14, 1980
DocketCiv. A. Nos. 79-765 to 79-767, 79-775 to 79-777, 79-875, 79-902, 79-1185 and 79-1262
StatusPublished
Cited by1 cases

This text of 495 F. Supp. 1185 (Way v. United States) is published on Counsel Stack Legal Research, covering District Court, W.D. Oklahoma primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Way v. United States, 495 F. Supp. 1185 (W.D. Okla. 1980).

Opinion

ORDER APPOINTING PANEL OF MEDICAL EXPERTS

SHERMAN G. FINESILVER, District Judge,

Sitting by Designation.

THESE MATTERS arise under the National Swine Flu Immunization Program of 1976 (Public Law 94-380; 42 U.S.C. § 247b(jMO) [hereinafter referred to as “Swine Flu Act”]. The Swine Flu Act became law on August 12,1976, and applies to all claims arising out of the administration of swine flu inoculations pursuant to the National Swine Flu Immunization Program of 1976.

[1186]*1186This order applies to all of the above captioned cases and embraces the following areas:

I. Appointment of The Panel of Medical Experts
II. Areas of Inquiry of The Panel
III. Duties of the Panel
IV. Report of The Panel
V. Panel Members’ Availability at Trial and For Deposition
VI. Responsibilities of Counsel
VII. Compensation of The Panel
VIII. Notice to Attorneys and Panel Members

I.

Appointment of The Panel of Medical Experts

Due to the technical complexity of certain issues involved in this litigation, the Court finds that the appointment of a Panel of Medical Experts will meaningfully assist in their resolution. We further find that the medical findings and conclusions of said Panel may significantly enhance settlement negotiations between the litigants and potentially lead to resolution of these cases without necessity of trial.

The following individuals are hereby appointed to the Panel of Medical Experts:

1. Stanley Appel, M.D.
Baylor College of Medicine Houston, Texas,
Department of Neurology
2. Leonard Kurland, M.D.
Mayo Clinic Rochester, Minnesota
Professor and Chairman, Department of
Medical Statistics and Epidemiology
3. Clark Millikan, M.D.
University of Utah School of Medicine
Salt Lake City, Utah Department of Neurology

The Panel will choose one of its members to serve as Chairperson. The Chairperson shall be responsible for submission of the Panel’s report to the Court and shall act as the Panel’s representative in dealing with the Court and the litigants.

II.

Areas of Inquiry of The Panel

With respect to each individual plaintiff, the Panel shall address itself to the following areas:

(1) the nature and extent of the injuries suffered by plaintiff;

(2) the causal connection, if any, between the injuries and the immunization;

(3) the prognosis of plaintiff’s condition and prospects for rehabilitation;

(4) the nature and extent of treatment which plaintiff will be required to undergo; and

WHERE THE PANEL DETERMINES THAT PLAINTIFF’S INJURY IS NOT GUILLAIN-BARRE SYNDROME, THE PANEL SHALL ADDRESS THIS ADDITIONAL AREA:

(5) what was known in the medical community prior to October 1976 about the causal relation between influenza immunization and the injury plaintiff contracted.

III.

Duties Of The Panel

The Panel shall select two members to conduct a physical examination of each plaintiff. The examination shall be conducted at a medical office, hospital or medical center in Oklahoma City, Oklahoma on a date within the period prescribed by the Court and at a time mutually convenient to both plaintiff and the Panel members. The physical examinations of plaintiffs shall be conducted no later than August 29, 1980. It is recommended that the examining physicians review plaintiff’s entire medical history prior to conducting the examination.

The Panel shall review and evaluate such documents and other materials submitted by the litigants and ordered by the Court. The Panel may request additional materials or information from the litigants as the circumstances warrant. The request shall [1187]*1187be made by the Chairperson of the Panel to the Court.

IV.

Report of The Panel

The Panel shall advise the Court and counsel in writing of its findings. Dissenting reports, if any, shall likewise be submitted. The findings shall be admissible in evidence at trial.

By September 15, 1980, the Panel shall submit in triplicate to the Clerk of the Court for the Western District of Oklahoma its reports) as to each individual plaintiff which shall contain:

(1) findings regarding the nature and extent of the injuries suffered by plaintiff since October, 1976;

(2) findings regarding the causal connection, if any, between the injuries and the immunization;

(3) findings regarding a prognosis of plaintiff’s condition and prospects for rehabilitation:

(4) findings regarding the nature and extent of treatment plaintiff will be required to undergo; and

WHERE THE PANEL HAS DETERMINED THAT PLAINTIFF’S INJURY IS NOT GUILLAIN-BARRE SYNDROME, THE PANEL SHALL MAKE THE FOLLOWING ADDITIONAL FINDINGS:

(5) findings regarding what was known in the medical community prior to October 1976 about the causal relation between influenza immunization and the injury plaintiff contracted.

The findings of the Panel shall include all facts and assumptions relied upon in reaching its conclusions, and the reasons which sustain those conclusions. The report shall highlight pertinent items in the medical history which are pivotal, verify any prior diagnosis and discuss whether the plaintiff’s course is typical of the malady from which plaintiff suffers.

V.

Panel Members’ Availability at Trial and For Deposition

Upon submission to the Court and the parties of the Panel’s report, the parties shall have 10 days in which to submit a request to the Court to take the deposition of any member of the Panel. The Court shall then schedule for each Panel member one (or more if needed) day(s) for deposition. On the day of the deposition, each party shall have an opportunity to examine the Panel member, but the examination shall be strictly limited to matters contained in the Panel’s report as to the respective plaintiff. The depositions may be used for any purpose permitted by the Federal Rules of Civil Procedure. Additionally, Panel members shall be subject to examination and cross-examination at trial.

The cost of a Panel member’s attendance at a deposition or attendance at trial shall be borne by the party requesting such attendance; if both parties request attendance, the cost shall be shared equally.

VI.

Responsibilities of Counsel

Free access — add to your briefcase to read the full text and ask questions with AI

Related

In Re Swine Flu Immunization Products Liability
495 F. Supp. 1185 (W.D. Oklahoma, 1980)

Cite This Page — Counsel Stack

Bluebook (online)
495 F. Supp. 1185, Counsel Stack Legal Research, https://law.counselstack.com/opinion/way-v-united-states-okwd-1980.